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Abstract
Background: Recent genome-wide association studies (GWASs) have reported several genetic variants to be reproducibly
associated with type 2 diabetes. Additional variants have also been detected from a metaanalysis of three GWASs,
performed in populations of European ancestry. In the present study, we evaluated the influence of 17 genetic variants from
15 candidate loci, identified in type 2 diabetes GWASs and the metaanalysis, in a Han Chinese cohort.
Methodology/Principal Findings: Selected type 2 diabetes–associated genetic variants were genotyped in 1,165 type 2
diabetic patients and 1,136 normoglycemic control individuals of Southern Han Chinese ancestry. The OR for risk of
developing type 2 diabetes was calculated using a logistic regression model adjusted for age, sex, and BMI. Genotype-
phenotype associations were tested using a multivariate linear regression model. Genetic variants in CDKN2A/B, CDKAL1,
TCF7L2, TCF2, MC4R, and PPARG showed a nominal association with type 2 diabetes (P#0.05), of whom the three first would
stand correction for multiple testing: CDKN2A/B rs10811661, OR: 1.26 (1.12–1.43) P=1.8*10
24; CDKAL1 rs10946398, OR: 1.23
(1.09–1.39); P=7.1*10
24, and TCF7L2 rs7903146, OR: 1.61 (1.19–2.18) P=2.3 * 10
23. Only nominal phenotype associations
were observed, notably for rs8050136 in FTO and fasting plasma glucose (P=0.002), postprandial plasma glucose (P=0.002),
and fasting C-peptide levels (P=0.006) in the diabetic patients, and with BMI in controls (P=0.033).
Conclusions/Significance: We have identified significant association between variants in CDKN2A/B, CDKAL1 and TCF7L2,
and type 2 diabetes in a Han Chinese cohort, indicating these genes as strong candidates conferring susceptibility to type 2
diabetes across different ethnicities.
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Introduction
Type 2 diabetes is a complex polygenic disorder characterized
by the presence of insulin resistance and pancreatic beta cell
dysfunction. Interactions between environmental and genetic
factors are involved in the onset and development of the disease.
The prevalence of type 2 diabetes is increasing rapidly worldwide
and China will be one of the countries hit hardest, with the
diabetic population more than doubling in the next 20 years [1].
Many genetic variants have been associated with type 2
diabetes, but from a long list of candidate genes only three have
unambiguously been associated with the disease: PPARG, KCNJ11
and TCF7L2 [2–4]. However, in 2007, several reproducible
genome-wide association studies (GWASs) confirmed these well-
established susceptibility genes and identified a number of new loci
(SLC30A8, HHEX, CDKN2A/B, IGF2BP2, GCKR, FTO, and
CDKAL1) at which common variants influence risk of type 2
diabetes in Europeans [5–10].
Intriguingly, another study in 2007 showed that a variant in
TCF2 was associated with increased risk of prostate cancer but
reduced risk of type 2 diabetes in individuals of European, African
and Asian descent [11]. Furthermore, a meta-analysis of three
GWASs detected six novel variants (in JAZF1, CDC123/CAMK1D,
TSPAN8/LGR5, THADA, ADAMTS9, and NOTCH2) that were
associated with type 2 diabetes [12]. Recently, two GWASs
established that a common genetic variant near MC4R gene
(rs17782313) was associated with increased obesity risk and insulin
resistance [13,14].
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SLC30A8, HHEX, CDKAL1, CDKN2A/B and IGF2BP2) might be
implicated in beta cell function [8–10,15–17]. In addition,
variation in GCKR, encoding glucokinase regulatory protein, and
FTO, the fat mass and obesity associated gene, were associated
with serum triglyceride and BMI respectively [5,6].
Most of the populations analyzed in the GWASs were of
European ancestry and the contributions of these genetic variants
in other ethnic groups are less clear. Nevertheless, some variants
associated with risk of type 2 diabetes identified by GWASs in
Europeans have been replicated in Asians. However, due to the
ethnic differences in risk allele frequencies, the impact of these
genes varies between these two ethnic groups [18–21]. Although
studies have failed to show association between the previously
reported risk allele rs7903146 in TCF7L2 with type 2 diabetes in
Chinese, it has been suggested that variations in this gene confer
risk of type 2 diabetes in this ethnic group. Interestingly, two other
TCF7L2 SNPs (rs11196218 and rs290487) were found to associate
with type 2 diabetes in Chinese [22–24]. Moreover, no study has
so far examined if the variants identified in the meta-analysis are
associated with type 2 diabetes in a Chinese population.
To obtain a global view of the role of these SNPs in the
pathogenesis of type 2 diabetes worldwide, it is important to test
associations between candidate SNPs and type 2 diabetes in
various ethnic groups. In the present study we therefore evaluated
the influence of 17 type 2 diabetes associated SNPs in 15 candidate
loci in a Han Chinese population. As some variants are known to
affect the risk of type 2 diabetes through obesity, and others have
shown the strongest association with related metabolic traits, we
also investigated the genetic impact on BMI, glucose levels, C-
peptide, and triglycerides.
Materials and Methods
Participants
All studied individuals were of Southern Han Chinese ancestry
residing in the Shanghai metropolitan area. 1165 type 2 diabetic
patients were recruited from the Endocrinology and Metabolism
outpatient clinics at Fudan University Huashan Hospital in
Shanghai, China. Type 2 diabetes mellitus was diagnosed
according to 1999 WHO criteria [25]. All diabetic patients were
unrelated and diagnosed after the age of 27 years. Known
subtypes of diabetes were excluded based on antibody measure-
ments and inheritance. The 1136 non-diabetic unrelated control
individuals were older than 45 years, had no family history of
diabetes mellitus and normal glucose tolerance was verified by an
OGTT. The clinical characteristics of participants are summa-
rized in Table 1. Measurement of C-peptide was only obtained for
the diabetics. Written informed consent was obtained from all
participants and the study was approved by the Ethics Committee
of Huashan Hospital affiliated to Fudan University.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using the conventional phenol/chloroform method. SNP selection
was based on published type 2 diabetes GWAS data and a meta-
analysis of those, as summarized in the introduction. SNPs in
NOTCH2, THADA and WFS1 were not included as they have a
MAF ,0.05 in Chinese as reported by the HapMap project,
which would limit the power to detect an association. Two of the
TCF7L2 polymorphisms (rs290487 and rs7903146) were geno-
typed using TaqMan allelic discrimination assays (Applied
Biosystems, Foster City, CA, USA). All other SNPs were
genotyped using iPLEX (Sequenom, San Diego, CA, USA) and
detected by matrix-assisted laser desorption/ionisation-time of
flight mass spectrometry. All analyzed SNPs are presented in
Table 2, except rs13266634 (SLC30A8), which failed genotyping
although applying two different methods. The genotype frequen-
cies were all in Hardy-Weinberg equilibrium (P.0.05) and 96
samples (4%) were run in duplicates with a 100% concordance
rate.
Statistical Analyses
The OR for risk of developing type 2 diabetes was calculated
using logistic regression, assuming an additive genetic model,
adjusted for age (age of diagnosis for cases and age at participation
for controls), sex and BMI. Power to detect an association was
calculated for each SNP using the Genetic Power Calculator [26],
assuming an additive model, a type 2 diabetes frequency of 6%,
using MAF as observed in the studied cohort, a=0.05, and effect
size (OR) as previously reported [2,3,5,11,12,22,23] (Table 2).
Multivariate linear regression analyses were used to test genotype-
phenotype correlations and adjusted for age, sex and BMI (apart
from the BMI phenotype). Non-normally distributed values were
log-transformed before analysis. All statistical analyses were
performed using either SPSS program version 14.0 for Windows
(SPSS, Chicago, IL, USA) or NCSS software, 2004 release (NCSS,
Kaysville, UT, USA).
Results
The clinical characteristics of participating individuals are
presented in Table 1.
Table 1. Clinical characteristics of the participants.
Type 2 diabetes cases Controls
N (male/female) 1165 (455/710) 1136 (353/783)
Age (years) 60.3610.9 59.167.9
BMI (kg/m
2) 25.263.4 24.163.0
Fasting C-peptide (nmol/l) 1.09 (0.62) n/a
Fasting plasma glucose (mmol/l) 8.463.0 5.260.4
2 h postprandial plasma glucose (mmol/l) 15.165.3 6.061.0
Triglycerides (mmol/l) 1.65 (1.15) 1.23 (0.87)
Data are expressed as mean 6 SD for normally distributed values (age, BMI and glucose) and median (IQR) for non-normally distributed values (C-peptide and
triglycerides).
doi:10.1371/journal.pone.0009153.t001
T2D Risk Alleles in Chinese
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9153Type 2 Diabetes Susceptibility SNPs and Association with
the Disease in Han Chinese
17 SNPs were analyzed for association with type 2 diabetes in
the studied Han Chinese individuals. Genotype and allele
frequencies are shown in Table 2 together with results of the
association analyses. Power to detect an association based on here
observed MAF and OR as reported previously varied from 5–
100%, with only five SNPs having more than 80% power (Table 2).
SNPs in CDKN2A/B, CDKAL1, TCF7L2, TCF2, MC4R and
PPARG showed a nominal association with type 2 diabetes
(P#0.05), of whom the three first would stand correction for
multiple testing: rs10811661, OR: 1.26 (1.12–1.43) P=1.8*10
24;
rs10946398, OR: 1.23 (1.09–1.39); P=7.1*10
24 and rs7903146,
OR: 1.61 (1.19–2.18) P=2.3*10
23 (Table 2). As both FTO and
MC4R are known to affect type 2 diabetes risk through modulation
of obesity, association was also calculated without adjustment for
BMI. Both variants showed a modest increase in OR and a slightly
lower P-value (rs8050136, OR: 1.18 (0.99–1.41) P=0.066 and
rs17782313, OR: 1.20 (1.04–1.39); P=0.015).
Association of 17 Genetic Variants Related to Type 2
Diabetes and Metabolic Quantitative Traits
We examined associations between all the analyzed SNPs and
metabolic quantitative traits in cases, controls and also in cases and
controls combined (except for the glucose phenotypes; Table S1).
The metabolic phenotypes tested include BMI, fasting plasma
glucose, 2 h postprandial plasma glucose, C-peptide (only for
cases) and triglycerides. No association was observed after
correction for multiple testing, although, the A allele of
rs8050136 (FTO) showed nominal associations with fasting plasma
glucose (P=0.002), postprandial plasma glucose (P=0.002) and
the fasting C-peptide levels (P=0.006) in the cases. There was no
association between this SNP and BMI in the diabetic cases, but
an association was found between the FTO SNP and BMI in the
Table 2. Genotypic and allelic distribution of type 2 diabetes susceptibility SNPs and association with type 2 diabetes in a Han
Chinese cohort.
Nearest gene(s) SNP
Alleles
a major/
minor MAF
Genotype Frequency T2D
Cases Controls
ORadd
(95% CI)
b P value
c Power
d
CDKN2A/B rs10811661 T/C 0.475 0.351/0.457/0.192
0.271/0.510/0.220
1.26
(1.12–1.43)
1.8*10
24 91%
CDKAL1 rs10946398 A/C 0.392 0.319/0.481/0.200
0.369/0.478/0.153
1.23
(1.09–1.39)
7.1*10
24 87%
TCF7L2 rs7903146 C/T 0.033 0.897/0.103/0.000
0.938/0.060/0.003
1.61
(1.19–2.18)
2.3*10
23 59%
TCF2 rs4430796 T/C 0.293 0.456/0.442/0.102
0.498/0.419/0.083
1.16
(1.02–1.32)
0.026 35%
MC4R rs17782313 T/C 0.191 0.610/0.340/0.050
0.652/0.312/0.035
1.18
(1.01–1.37)
0.032 13%
PPARG rs1801282 C/G 0.064 0.901/0.099/0.000
0.877/0.118/0.005
1.30
(1.00–1.68)
0.050 46%
JAZF1 rs864745 A/G 0.225 0.643/0.316/0.041
0.608/0.334/0.058
1.16
(1.00–1.34)
0.054 29%
HHEX/IDE rs1111875 T/C 0.279 0.485/0.423/0.092
0.517/0.408/0.075
1.14
(1.00–1.30)
0.056 52%
GCKR rs780094 T/C 0.481 0.283/0.519/0.197
0.260/0.520/0.221
1.11
(0.98–1.26)
0.088 5%
IGF2BP2 rs4402960 C/A 0.253 0.541/0.378/0.081
0.565/0.364/0.071
1.12
(0.98–1.28)
0.11 71%
FTO rs8050136 C/A 0.119 0.748/0.236/0.016
0.774/0.216/0.011
1.15
(0.96–1.38)
0.14 47%
KCNJ11 rs5219 G/A 0.398 0.339/0.504/0.157
0.374/0.455/0.170
1.07
(0.95–1.21)
0.26 96%
TCF7L2 rs11196218 G/A 0.262 0.509/0.444/0.050
0.549/0.378/0.073
1.07
(0.93–1.23)
0.34 100%
TSPAN8/LGR5 rs7961581 T/C 0.202 0.636/0.311/0.053
0.638/0.321/0.041
1.05
(0.90–1.22)
0.55 24%
TCF7L2 rs290487 T/C 0.362 0.404/0.462/0.134
0.409/0.461/0.131
1.00
(0.88–1.13)
0.99 100%
CDC123/CAMK1D rs12779790 A/G 0.164 0.697/0.268/0.036
0.699/0.276/0.026
1.02
(0.87–1.20)
0.80 29%
ADAMTS9 rs4607103 C/T 0.369 0.408/0.446/0.145
0.406/0.450/0.144
1.00
(0.89–1.13)
0.96 32%
aRisk allele denoted in bold.
bCalculated using logistic regression, assuming an additive model adjusted for age, sex and BMI.
cP-values shown are not corrected for multiple testing.
dAssuming an additive model, a T2D frequency of 6%, a=0.05, MAF based on this study and OR as previously reported.
MAF, minor allele frequency in control samples; T2D, type 2 diabetes.
doi:10.1371/journal.pone.0009153.t002
T2D Risk Alleles in Chinese
PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9153non-diabetic controls and when combining all individuals
(P=0.033 and 0.031 respectively). Additionally, the risk C allele
of rs10946398 (CDKAL1) suggest an increase in fasting plasma
glucose in normoglycemic controls (P=0.016) and a nominal
association was also observed between the A allele of rs11196218
(TCF7L2) and a decrease in C-peptide in the cases (Table S1).
Discussion
In the present study, we analyzed 17 SNPs in a type 2 diabetes
case-control cohort comprising 2301 Han Chinese individuals.
The majority of the investigated SNPs have previously been
identified conferring risk of type 2 diabetes, but these studies were
mainly performed in Europeans. We replicated previous findings
of associations for three SNPs in this Chinese population
(rs10811661 in CDKN2A/B, rs10946398 in CDKAL1, and
rs7903146 in TCF7L2) suggesting that some of the variants
associated with type 2 diabetes in Europeans are also associated
with the disease in Asians. In addition, we have previously
reported an association for MTNR1B and type 2 diabetes in this
cohort [21].
GWASs have recently described novel type 2 diabetes
susceptibility loci, including several previously unknown genomic
regions, such as CDKN2A/B and CDKAL1 [5,7–10]. We observed a
significant association between CDKN2A/B rs10811661 and type 2
diabetes (OR: 1.26, P=1.8*10
24) in Chinese. The OR in our
study is similar to the one reported in Europeans (OR: 1.20)
[5,7,10]. However, the risk allele (T) is less prevalent in Chinese
Hans (risk allele frequency =0.52) compared with Europeans (risk
allele frequency =0.83) [5]. We also replicated the diabetes
susceptibility variant rs10946398 in CDKAL1 (OR: 1.2,
P=7.1*10
24). Our results support previous findings that these
variants in CDKN2A/B and CDKAL1 individually contribute to the
risk of type 2 diabetes in the Han Chinese population [20,22], but
imply some ethnic differences between Europeans and Asians.
The TCF7L2 polymorphism rs7903146 is the strongest single
genetic variant associated with type 2 diabetes [4,5,7,8,10] and has
been convincingly replicated in multiple populations [27–30]. In
contrast to populations of European and African ancestries, the
risk T-allele of rs7903146 was rare in our studied Chinese cohort
with a MAF of 3.3%. This is in concordance with the data
reported by the HapMap project [31]. However, in contrast to
earlier studies performed in Chinese cohorts [22–24], we found a
significant association between rs7903146 and type 2 diabetes
(OR=1.61, P=2.3*10
23). The inability to detect this association
in the previous Chinese studies may be due to insufficient power.
Notably, we could not replicate two other susceptibility SNPs in
TCF7L2 (rs11196218 and rs290487), previously reported to be
associated with type 2 diabetes in Chinese studies [22,23].
However, we did identify a consistent association of this gene
with type 2 diabetes in our Chinese population, further validating
the contribution of TCF7L2 on susceptibility to the disease. Since
the risk allele frequency of rs7903146 is lower in Chinese
compared with i.e. Europeans, the genetic contribution of this
polymorphism to type 2 diabetes on a population level is relatively
small. Interestingly, two recent case-control studies independently
reported significant associations between rs7903146 and type 2
diabetes in the Japanese [32,33], supporting our result that
rs7903146 may contribute to diabetes susceptibility in East Asian
populations.
None of the other investigated SNPs showed significant
association with type 2 diabetes in our cohort. This may be
explained by different environmental risk profiles between
Europeans and Asians, body composition and genetic back-
grounds, or that we have insufficient power with current sample
size to replicate some of these previously reported risk variants.
Moreover, our study is the first to investigate the SNPs identified
by a meta-analysis of three GWASs [12] in a Chinese case-control
cohort. However, it is not unexpected that our study was unable to
find significant associations between SNPs in JAZF1, CDC123/
CAMK1D, TSPAN8/LGR5 and ADAMTS9 and type 2 diabetes,
since the meta-analysis required more than 9000 samples for an
80% power [12].
Of all the analyzed SNPs, FTO showed the strongest association
with metabolic traits. There was a trend towards elevated levels of
fasting plasma glucose and 2 h postprandial glucose in the diabetic
A-allele carriers, as well as a decreased level of fasting C-peptide in
the same group. In this study, we also confirmed a nominal
association between rs8050136 and BMI in non-diabetic controls.
The association between FTO and obesity has been shown to
indirectly modulate risk of type 2 diabetes in Europeans [6,10,34],
but it has been difficult to demonstrate an association between
FTO (rs8050136) and obesity or BMI in Asians [35–37].
Nevertheless, our result, together with data from Ng et al. [19],
indicates that FTO also affects BMI in Asians.
In summary, we have identified significant associations between
variants in CDKN2A/B, CDKAL1 and TCF7L2 and type 2 diabetes
in a Han Chinese population. Our results indicate that these genes
are strong candidates conferring susceptibility to type 2 diabetes
across different ethnicities. However, more comprehensive studies
in larger populations of different ethnic backgrounds are needed to
clarify the molecular mechanisms and underlying genetic
architecture of type 2 diabetes.
Supporting Information
Table S1 Effect of studied genetic variants on metabolic
quantitative traits in type 2 diabetic cases and normoglycemic
controls.
Found at: doi:10.1371/journal.pone.0009153.s001 (0.28 MB
DOC)
Author Contributions
Conceived and designed the experiments: TR ZY BL YD CAL RH.
Performed the experiments: JW TR AO RH. Analyzed the data: JW TR
AO CAL RH. Contributed reagents/materials/analysis tools: ZY BL YD
CAL. Wrote the paper: JW TR AO CAL RH.
References
1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of
diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:
1047–1053.
2. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, et al.
(2000) The common PPARgamma Pro12Ala polymorphism is associated with
decreased risk of type 2 diabetes. Nat Genet 26: 76–80.
3. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, et al. (2003) Large-
scale association studies of variants in genes encoding the pancreatic beta-cell
KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the
KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52: 568–572.
4. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al.
(2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type
2 diabetes. Nat Genet 38: 320–323.
5. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007)
Genome-wide association analysis identifies loci for type 2 diabetes and
triglyceride levels. Science 316: 1331–1336.
6. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007)
A common variant in the FTO gene is associated with body mass index
and predisposes to childhood and adult obesity. Science 316: 889–
894.
T2D Risk Alleles in Chinese
PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e91537. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-
wide association study of type 2 diabetes in Finns detects multiple susceptibility
variants. Science 316: 1341–1345.
8. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide
association study identifies novel risk loci for type 2 diabetes. Nature 445:
881–885.
9. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T,
et al. (2007) A variant in CDKAL1 influences insulin response and risk of type 2
diabetes. Nat Genet 39: 770–775.
10. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007)
Replication of genome-wide association signals in UK samples reveals risk loci
for type 2 diabetes. Science 316: 1336–1341.
11. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G,
et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and
the one in TCF2 protects against type 2 diabetes. Nat Genet 39: 977–983.
12. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-
analysis of genome-wide association data and large-scale replication identifies
additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638–645.
13. Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, et al. (2008) Common
genetic variation near MC4R is associated with waist circumference and insulin
resistance. Nat Genet 40: 716–718.
14. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, et al. (2008) Common
variants near MC4R are associated with fat mass, weight and risk of obesity. Nat
Genet 40: 768–775.
15. Palmer ND, Goodarzi MO, Langefeld CD, Ziegler J, Norris JM, et al. (2008)
Quantitative trait analysis of type 2 diabetes susceptibility loci identified from
whole genome association studies in the Insulin Resistance Atherosclerosis
Family Study. Diabetes 57: 1093–1100.
16. Staiger H, Machicao F, Stefan N, Tschritter O, Thamer C, et al. (2007)
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell
function. PLoS ONE 2: e832.
17. Grarup N, Rose CS, Andersson EA, Andersen G, Nielsen AL, et al. (2007)
Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2
genes with type 2 diabetes and impaired insulin release in 10,705 Danish
subjects: validation and extension of genome-wide association studies. Diabetes
56: 3105–3111.
18. Liu Y, Yu L, Zhang D, Chen Z, Zhou DZ, et al. (2008) Positive association
between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals.
Diabetologia 51: 2134–2137.
19. Ng MC, Park KS, Oh B, Tam CH, Cho YM, et al. (2008) Implication of genetic
variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2,
and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57:
2226–2233.
20. Wu Y, Li H, Loos RJ, Yu Z, Ye X, et al. (2008) Common variants in CDKAL1,
CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with
type 2 diabetes and impaired fasting glucose in a Chinese Han population.
Diabetes 57: 2834–2842.
21. Ronn T, Wen J, Yang Z, Lu B, Du Y, et al. (2009) A common variant in
MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes
and fasting plasma glucose in Han Chinese individuals. Diabetologia.
22. Ng MC, Tam CH, Lam VK, So WY, Ma RC, et al. (2007) Replication and
identification of novel variants at TCF7L2 associated with type 2 diabetes in
Hong Kong Chinese. J Clin Endocrinol Metab 92: 3733–3737.
23. Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, et al. (2007) Association
study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2)
gene and type 2 diabetes in the Chinese population. Diabetes 56: 2631–2637.
24. Ren Q, Han XY, Wang F, Zhang XY, Han LC, et al. (2008) Exon sequencing
and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a
Chinese population. Diabetologia 51: 1146–1152.
25. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:
539–553.
26. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of
linkage and association genetic mapping studies of complex traits. Bioinformatics
19: 149–150.
27. Humphries SE, Gable D, Cooper JA, Ireland H, Stephens JW, et al. (2006)
Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in
UK European Whites, Indian Asians and Afro-Caribbean men and women.
J Mol Med 84: 1005–1014.
28. Zhang C, Qi L, Hunter DJ, Meigs JB, Manson JE, et al. (2006) Variant of
transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in
large cohorts of U.S. women and men. Diabetes 55: 2645–2648.
29. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, et al.
(2007) Common variants in the TCF7L2 gene are strongly associated with type 2
diabetes mellitus in the Indian population. Diabetologia 50: 63–67.
30. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, et al. (2006) Transcription
factor TCF7L2 genetic study in the French population: expression in human
beta-cells and adipose tissue and strong association with type 2 diabetes.
Diabetes 55: 2903–2908.
31. (2003) The International HapMap Project. Nature 426: 789–796.
32. Hayashi T, Iwamoto Y, Kaku K, Hirose H, Maeda S (2007) Replication study
for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese
population. Diabetologia 50: 980–984.
33. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, et al. (2007) A genetic
variation of the transcription factor 7-like 2 gene is associated with risk of type 2
diabetes in the Japanese population. Diabetologia 50: 747–751.
34. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, et al. (2007) Genome-wide
association scan shows genetic variants in the FTO gene are associated with
obesity-related traits. PLoS Genet 3: e115.
35. Horikoshi M, Hara K, Ito C, Shojima N, Nagai R, et al. (2007) Variations in the
HHEX gene are associated with increased risk of type 2 diabetes in the Japanese
population. Diabetologia 50: 2461–2466.
36. Li H, Wu Y, Loos RJ, Hu FB, Liu Y, et al. (2008) Variants in the fat mass- and
obesity-associated (FTO) gene are not associated with obesity in a Chinese Han
population. Diabetes 57: 264–268.
37. Yajnik CS, Janipalli CS, Bhaskar S, Kulkarni SR, Freathy RM, et al. (2009)
FTO gene variants are strongly associated with type 2 diabetes in South Asian
Indians. Diabetologia 52: 247–252.
T2D Risk Alleles in Chinese
PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e9153